Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer's Disease
N-Palmitoylethanolamide (PEA) is a non-endocannabinoid lipid mediator belonging to the class of the N-acylethanolamine phospolipids and was firstly isolated from soy lecithin, egg yolk, and peanut meal. Either preclinical or clinical studies indicate that PEA is potentially useful in a wide range of...
Saved in:
Main Authors: | Sarah Beggiato (Author), Maria Cristina Tomasini (Author), Luca Ferraro (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vitro Functional Characterization of GET73 as Possible Negative Allosteric Modulator of Metabotropic Glutamate Receptor 5
by: Sarah Beggiato, et al.
Published: (2018) -
Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration
by: Maria Cristina Bonferoni, et al.
Published: (2019) -
Adenosine and Kynurenic Acid Interactions: Possible Relevance for Schizophrenia Treatment?
by: Sarah Beggiato, et al.
Published: (2021) -
Geraniol Pharmacokinetics, Bioavailability and Its Multiple Effects on the Liver Antioxidant and Xenobiotic-Metabolizing Enzymes
by: Barbara Pavan, et al.
Published: (2018) -
Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
by: Annalisa Noce, et al.
Published: (2021)